679 related articles for article (PubMed ID: 22193532)
21. Neuropsychological correlates of behavioral symptoms in Alzheimer's disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study.
Perri R; Monaco M; Fadda L; Caltagirone C; Carlesimo GA
J Alzheimers Dis; 2014; 39(3):669-77. PubMed ID: 24254701
[TBL] [Abstract][Full Text] [Related]
22. Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's Disease.
Ritchie CW; Khandker RK; Pike J; Black CM; Jones E; Ambegaonkar BM
J Alzheimers Dis; 2018; 64(3):899-910. PubMed ID: 29966202
[TBL] [Abstract][Full Text] [Related]
23. Galantamine treatment of vascular dementia: a randomized trial.
Auchus AP; Brashear HR; Salloway S; Korczyn AD; De Deyn PP; Gassmann-Mayer C;
Neurology; 2007 Jul; 69(5):448-58. PubMed ID: 17664404
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal changes in awareness over 36 months in patients with mild Alzheimer's disease.
Vogel A; Waldorff FB; Waldemar G
Int Psychogeriatr; 2015 Jan; 27(1):95-102. PubMed ID: 25075811
[TBL] [Abstract][Full Text] [Related]
25. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
[TBL] [Abstract][Full Text] [Related]
26. General measures of cognition.
Ferris SH
Int Psychogeriatr; 2003; 15 Suppl 1():215-7. PubMed ID: 16191243
[TBL] [Abstract][Full Text] [Related]
27. Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes.
Ascher-Svanum H; Chen YF; Hake A; Kahle-Wrobleski K; Schuster D; Kendall D; Heine RJ
Clin Ther; 2015 Jun; 37(6):1195-205. PubMed ID: 25676448
[TBL] [Abstract][Full Text] [Related]
28. [Relationship between arterial pressure and cognitive functions. Data for the French Network on Alzheimer's disease (REAL.FR)].
Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS
Rev Med Interne; 2003 Oct; 24 Suppl 3():292s-300s. PubMed ID: 14710447
[TBL] [Abstract][Full Text] [Related]
29. Utilization of Observational Data as a Proxy Cohort for Comparison Purposes with Open-Label Study Results: An Example from Alzheimer's Disease.
Reed C; Happich M; Raskin J; Tockhorn-Heidenreich A; Belger M
J Prev Alzheimers Dis; 2019; 6(2):90-99. PubMed ID: 30756115
[TBL] [Abstract][Full Text] [Related]
30. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
[TBL] [Abstract][Full Text] [Related]
31. Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: relationship to motor disability and cognitive deficits: a pilot study.
Rasovska H; Rektorova I
J Neurol Sci; 2011 Nov; 310(1-2):279-82. PubMed ID: 21851954
[TBL] [Abstract][Full Text] [Related]
32. Disease progression meta-analysis model in Alzheimer's disease.
Ito K; Ahadieh S; Corrigan B; French J; Fullerton T; Tensfeldt T;
Alzheimers Dement; 2010 Jan; 6(1):39-53. PubMed ID: 19592311
[TBL] [Abstract][Full Text] [Related]
33. Asymptomatic spontaneous cerebral emboli and cognitive decline in a cohort of older people: a prospective study.
Voshaar RC; Purandare N; Hardicre J; McCollum C; Burns A
Int J Geriatr Psychiatry; 2007 Aug; 22(8):794-800. PubMed ID: 17192026
[TBL] [Abstract][Full Text] [Related]
34. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study.
Riekse RG; Leverenz JB; McCormick W; Bowen JD; Teri L; Nochlin D; Simpson K; Eugenio C; Larson EB; Tsuang D
J Am Geriatr Soc; 2004 Sep; 52(9):1442-8. PubMed ID: 15341544
[TBL] [Abstract][Full Text] [Related]
35. Neuropsychiatric symptoms in patients with Alzheimer's disease with a vascular component.
Bidzan M; Bidzan L; Pachalska M
Ann Agric Environ Med; 2014; 21(2):412-5. PubMed ID: 24959800
[TBL] [Abstract][Full Text] [Related]
36. Modeling Alzheimer's disease progression using the disease system analysis approach.
Gomeni R; Simeoni M; Zvartau-Hind M; Irizarry MC; Austin D; Gold M
Alzheimers Dement; 2012 Jan; 8(1):39-50. PubMed ID: 21782528
[TBL] [Abstract][Full Text] [Related]
37. Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.
Helmer C; Andrieu S; Pérès K; Orgogozo JM; Vellas B; Dartigues JF;
Dement Geriatr Cogn Disord; 2007; 23(3):168-74. PubMed ID: 17215578
[TBL] [Abstract][Full Text] [Related]
38. Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline.
Amieva H; Mokri H; Le Goff M; Meillon C; Jacqmin-Gadda H; Foubert-Samier A; Orgogozo JM; Stern Y; Dartigues JF
Brain; 2014 Apr; 137(Pt 4):1167-75. PubMed ID: 24578544
[TBL] [Abstract][Full Text] [Related]
39. Silent cerebrovascular events and Alzheimer's disease: an overlooked opportunity for prevention?
Doraiswamy PM
Am J Psychiatry; 2012 Mar; 169(3):251-4. PubMed ID: 22407112
[No Abstract] [Full Text] [Related]
40. The correlation between cerebral arterial pulsatility and cognitive dysfunction in Alzheimer's disease patients.
Lim JS; Lee JY; Kwon HM; Lee YS
J Neurol Sci; 2017 Feb; 373():285-288. PubMed ID: 28131207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
